Goldman Sachs’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-12,800
Closed -$1.46M 5639
2018
Q3
$1.46M Buy
+12,800
New +$1.45M ﹤0.01% 3802
2017
Q1
Sell
-12,800
Closed -$863K 6993
2016
Q4
$863K Buy
+12,800
New +$868K ﹤0.01% 4583
2016
Q3
Sell
-5,000
Closed -$344K 7180
2016
Q2
$344K Buy
+5,000
New +$350K ﹤0.01% 5222

Other funds holding STE

Goldman Sachs's STE Position: Q1 2026 in Review

Goldman Sachs reduced its Steris (STE) stake by 40% in Q1 2026, selling an estimated $62.1M and leaving 381,577 shares worth $84.4M. The position accounts for 0.01% of the portfolio, ranked #1160.

Goldman Sachs first reported a position in STE in Q2 2013 and has held it in 52 quarters since. The position peaked at $161M in Q4 2025. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Goldman Sachs held 381,577 shares of Steris worth $84.4M as of Q1 2026.
  • Goldman Sachs sold 253,720 Steris shares in Q1 2026, an estimated $62.1M.
  • Steris made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1160 holding.
  • Goldman Sachs first reported a position in Steris in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Steris position peaked at $161M in Q4 2025.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.